Name: UMIN ID:
Unique ID issued by UMIN | UMIN000022437 |
---|---|
Receipt number | R000025859 |
Scientific Title | TAS-102 and Bevacizumab as second line chemotherapy for colorectal cancer. Phase 2 trial |
Date of disclosure of the study information | 2016/08/01 |
Last modified on | 2016/05/24 20:25:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/05/24 20:01:58 | ||
2 | Update | 2016/05/24 20:25:39 | Acronym Acronym |